# A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

Study · id `cardio:ct-nct01176240` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01176240](<https://clinicaltrials.gov/study/NCT01176240>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01176240

Browse, organ or system: Blood vessels  
Browse, condition area: Risk and prevention  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 225 participants.

## Technical summary

Registry record NCT01176240. Randomized; quadruple masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2012-10 (actual). Results posted on 2014-05-20.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 225 participants (enrolled count; ClinicalTrials.gov record NCT01176240, source copy `cardio:ctgov-nct01176240-2014-05-20`, retrieved 2026-10-31)
- Start date: 2010-06 (registry gives no type) (ClinicalTrials.gov record NCT01176240, source copy `cardio:ctgov-nct01176240-2014-05-20`, retrieved 2026-10-31)
- Primary completion: 2012-10 (actual) (ClinicalTrials.gov record NCT01176240, source copy `cardio:ctgov-nct01176240-2014-05-20`, retrieved 2026-10-31)
- Completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01176240, source copy `cardio:ctgov-nct01176240-2014-05-20`, retrieved 2026-10-31)
- Results first posted: 2014-05-20 (ClinicalTrials.gov record NCT01176240, source copy `cardio:ctgov-nct01176240-2014-05-20`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01176240, source copy `cardio:ctgov-nct01176240-2014-05-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01176240-2014-05-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
- Acronym: 306A/306B
- Condition: Orthostatic Hypotension
- Condition: Parkinson's Disease
- Intervention (Drug): Droxidopa
- Intervention (Other): Placebo
- Lead sponsor: Chelsea Therapeutics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Orthostatic hypotension (`cardio:orthostatic-hypotension`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A) (`cardio:pubmed-24326693`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9a6694232a2d657d8c5af717a53d80fec9e9fa450085336453153df0e306f12c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
